By analysing DNA from blood samples, Tvaster Genkalp is working to make cancer diagnostics more accessible, accurate, and ...

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, today announced late-breaking clinical data from ...

Ahead of Parents' Day, a 54-year-old son presented a healthy new life to a 75-year-old mother through liver transplantation.

The risk of dying from the most common form of primary liver cancer is approximately 30% higher for patients with low ...

The risk of dying from the most common form of primary liver cancer is about 30% higher for patients with low household ...

TWO toilet related symptoms could be the first signs of a hard-to-spot cancer that’s on the rise in the UK. Bile duct cancer ...

The risk of dying from the most common form of primary liver cancer is about 30 percent higher for patients with low household income compared to those with middle or high household income, according ...

Among patients with hepatocellular carcinoma, MAFLD was not an independent predictor for overall survival or progression-free survival.

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

ACG released new guidance for the management of malnutrition in patients with liver disease, including the newly renamed ...

A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...

There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to ...